AI drug development
| Published October 30, 2025

Recipharm secures new multi-million grant from the Gates Foundation

Text: Kim Liedholm | [email protected]
Recipharm is deepening its focus on next-generation vaccine manufacturing after receiving another major grant from the Bill & Melinda Gates Foundation. The new support will fund the development of AI-powered...

You need to create a user account to read this article.

With a subscription you unlock more content on BioStock.